Advertisements

Adco-Dapamax

Quick links to important sections

Adco-Dapamax

Advertisements
Advertisements

Treatment option: Hypertension

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Adco-Dapamax

Quick Facts

Property Description
Active ingredient Indapamid (Indapamide)
Form Oral Tablet (standard and sustained-release)
Pharmacological class Thiazide-like Diuretic, Antihypertensive Agent
General purpose Manage circulatory pressure and fluid volume
Origin Synthetic Sulfonamide Derivative

What Type of Medicine is Adco-Dapamax?

Adco-Dapamax is a brand-specific, prescription-only medication whose active component is Indapamid (INN), a single-ingredient drug classified as a thiazide-like diuretic and an antihypertensive agent. This dual classification defines its fundamental role in managing conditions related to the circulatory system. Indapamid is a synthetic chemical compound derived from the sulfonamide class. Indapamid is utilized for pressure control across various populations.

Composition and Available Formulations

Adco-Dapamax is composed solely of the active ingredient Indapamid combined with standard pharmaceutical excipients necessary for its delivery. As a single-ingredient product, its function is strictly tied to the properties of Indapamid, whose precise chemical structure is defined by the formula C16H16ClN3O3S. This medication is exclusively formulated for oral administration in the form of a tablet.

A key feature is the availability of sustained-release formulations. These formulations are designed to ensure the medication is released slowly and consistently over an extended period, which supports effective once-daily dosing and consistent maintenance therapy.

General Purpose and Physiological Action

The overarching purpose of Adco-Dapamax is to provide foundational therapeutic support by normalizing pressure within the circulatory system and aiding in the control of excessive fluid volume. It achieves this via a recognized dual action mechanism. One effect involves promoting the kidneys' increased excretion of excess salt and water (diuresis), and the other is the direct relaxation and widening of the blood vessels. This combination of fluid and salt regulation and blood vessel relaxation works to reduce the overall workload on the heart and arterial system, easing circulatory effort.

Advertisements

What side effects are possible with Adco-Dapamax?

Possible Side Effects and Safety Information

The safety profile for Adco-Dapamax (Indapamide) is structured around potential shifts in the body's fluid and electrolyte balance, as documented in official prescribing information from regulatory authorities. This classification identifies adverse reactions by frequency and the physiological system affected.

Regulatory Classification of Adverse Reactions

The most frequently classified reactions fall under Metabolism and Nutrition Disorders, primarily involving changes in blood chemistry. Hypokalemia (low potassium) is the most common electrolyte disturbance noted in the regulatory documents, often accompanied by general complaints such as headache, dizziness, and fatigue, which are classified as common.

Reactions are also categorized by the body system affected:

System Organ Class Example of Adverse Reaction (Regulatory Terminology)
Metabolism and Nutrition Hypokalemia, Hyponatremia, Hyperglycemia
Nervous System Headache, Dizziness, Vertigo
Skin and Subcutaneous Tissue Rash, Photosensitivity reactions
Eye Disorders Acute angle-closure glaucoma, Transient myopia

Serious Adverse Reactions and Safety Constraints

The official label highlights the potential for serious, though rare, adverse reactions, including the risk of Severe Electrolyte Imbalance that may precipitate cardiac events such as Torsades de pointes. Other documented serious risks involve the precipitation of Hepatic Encephalopathy in individuals with pre-existing severe liver impairment and Acute Angle-Closure Glaucoma, an idiosyncratic ocular reaction linked to sulfonamide derivatives.

The use of Adco-Dapamax is strictly contraindicated (prohibited) in patients with known hypersensitivity to sulfonamide drugs, pre-existing hypokalemia, severe renal failure, or severe hepatic failure.

Population-Specific Safety Considerations

Safety data specifies that older adults may be at an increased risk for severe electrolyte abnormalities, such as Hyponatremia. Furthermore, the safety and efficacy of Adco-Dapamax have not been established for use in children and adolescents, and it is not recommended for this population.

Advertisements

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Overdose involving Adco-Dapamax, whose active ingredient is Indapamide, is primarily characterized by an exaggeration of its effects on fluid and electrolyte balance, as documented in regulatory prescribing information.

Official labeling describes manifestations related to volume depletion and severe salt loss, including:

  • Systemic Symptoms: Lethargy, drowsiness, generalized weakness, vomiting, and muscle cramps.
  • Physiological Signs: Profound diuresis, significantly low blood pressure (hypotension), and rapid heart rate (tachycardia).

The most serious outcomes are tied to severe electrolyte disturbances, particularly hyponatremia and hypokalemia. These imbalances may lead to potentially fatal complications such as Torsade de pointes and other cardiac dysrhythmias. In patients with severe liver impairment, the risk of hepatic coma is documented. Specific populations, including the elderly and those with severe renal or hepatic disease, are noted to be at a heightened risk for severe outcomes.

When to Seek Help

Government regulatory bodies uniformly mandate seeking immediate medical attention for any suspected overdose. The management approach is described as symptomatic and supportive, focusing on correcting the fluid and electrolyte imbalances. Procedures may include gastric lavage and careful monitoring of plasma electrolytes and cardiac function.

Advertisements

Therapeutic Uses of Adco-Dapamax

What Adco-Dapamax Treats: Main Uses and Benefits

Sustaining Control Over Chronic High Blood Pressure

Adco-Dapamax is commonly used to manage essential hypertension, addressing symptoms related to sustained, elevated arterial pressure. Its therapeutic benefit is centered on the long-term management of circulatory pressure, which may assist with maintaining functional stability and supports the body in managing the long-term stress associated with hypertension. This provides supportive relief to patients to maintain control over their chronic condition and may help reduce the risk of future cardiovascular events. The therapeutic scope includes use for both chronic high blood pressure and fluid retention.

Alleviating Symptoms of Fluid and Volume Overload

The medication is commonly used across conditions presenting with significant symptomatic burden, including high blood pressure and fluid retention symptoms.

“The medication is applied when conditions involve persistent systemic imbalance related to pressure or fluid.”

It is relevant for easing symptoms that create noticeable physiological strain, such as swelling in the limbs. This supportive effect may assist with maintaining functional stability and supports general well-being during periods of heightened symptoms related to fluid accumulation.

Quick Facts: Therapeutic Scope Description
Primary Focus Sustained management of elevated arterial pressure.
Symptom Support Easing of swelling associated with fluid retention.
Clinical Context Long-term maintenance therapy for chronic circulatory conditions.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Adco-Dapamax?

Adco-Dapamax (Indapamide) is a prescription medicine whose eligibility is strictly defined by regulatory criteria, encompassing specific medical conditions and physiological states. Use is generally restricted to the adult population for established indications.

Absolute Contraindications (Must Not Use)

Official regulatory labeling dictates that Adco-Dapamax is contraindicated (absolutely prohibited) for use in patients with:

  • Severe Renal or Hepatic Impairment: Including conditions like anuria or hepatic encephalopathy.
  • Hypersensitivity: Allergy to Indapamide or any sulfonamide derivatives (sulfa drugs).
  • Hypokalaemia: Clinically significant low potassium levels.
  • Pregnancy and Lactation: Contraindicated during the second and third trimesters of pregnancy and while breastfeeding.

Restricted or Conditional Use

Certain groups may use the medicine only under special caution and monitoring:

  • Older Adults (Geriatrics): Use requires consideration of individual renal function.
  • Comorbid Conditions: Caution is required for patients with mild to moderate hepatic impairment, Systemic Lupus Erythematosus (SLE), or conditions that predispose to gout or severe electrolyte imbalance.
  • Pediatrics (< 18 Years): Safety and effectiveness are not established in children; use is not recommended.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Adco-Dapamax (Indapamide) interacts with several medicinal products and substances, as formally documented in regulatory prescribing information. These interactions are classified based on their potential to affect the drug’s efficacy or increase the risk of specific pharmacological events.

Contraindicated and High-Risk Combinations

Co-administration is formally restricted or contraindicated with Lithium because Indapamide reduces its renal clearance, resulting in elevated plasma concentrations and a high risk of toxicity. Numerous agents that prolong the QTc interval, including specific antiarrhythmics (such as Sotalol and Amiodarone) and non-antiarrhythmic medicines, are restricted. This is due to a heightened pharmacodynamic risk of ventricular arrhythmias, which is compounded by Indapamide-induced hypokalaemia.

Pharmacological and Efficacy Interactions

The concurrent use of systemic Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including high-dose Acetylsalicylic acid, may cause a documented reduction in the antihypertensive effect. Furthermore, a specific restriction exists for Simvastatin, where the dose must not exceed 20 mg daily when co-administered. Combinations with other agents that cause hypokalaemia, such as glucocorticoids or stimulant laxatives, increase the additive risk of potassium loss.

Specific Contexts and Populations

Official labeling notes that the co-administration of Alcohol may have an additive effect in lowering blood pressure. High salt or sodium intake is documented to potentially reduce the efficacy of Indapamide. The combination of Indapamide and Aliskiren is contraindicated in diabetic patients. Additionally, caution is noted in patients with severe hepatic impairment due to the risk of precipitating hepatic encephalopathy.

Advertisements

Mechanism of Action

How Adco-Dapamax works

Adco-Dapamax acts through selective inhibition of a transport protein within the renal tubules, initiating systemic changes that influence glucose handling and cardiorenal dynamics.


Inhibition of Renal Glucose Reabsorption

The drug is a highly selective Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor. This interaction targets SGLT2, which is responsible for the majority of glucose reabsorption in the proximal convoluted tubules of the kidney. By blocking SGLT2, Adco-Dapamax prevents the filtered glucose from being returned to the systemic circulation. This results in an increase in urinary glucose excretion (glucosuria), which modulates systemic glucose levels.


Cardiorenal Hemodynamic Modulation

SGLT2 inhibition simultaneously reduces the reabsorption of sodium that is co-transported with glucose. This molecular step increases the distal delivery of sodium and water, resulting in osmotic diuresis and natriuresis (increased excretion of water and sodium). These fluid and electrolyte shifts engage mechanisms that influence tubuloglomerular feedback (TGF), leading to a decrease in intraglomerular pressure and affecting overall cardiac workload. This cascade contributes to the drug's influence on renal autoregulation and cardiovascular dynamics.

Advertisements

Dosage and Administration Information

How Adco-Dapamax is Used: Official Dosing and Administration

Adco-Dapamax (Indapamide) is a prescription-only medication whose use is governed by specific medical protocols and clinical guidelines.

Administration and Dosage Forms

Adco-Dapamax is designed exclusively for oral administration. It is available as standard tablets in strengths like 1.25 mg and 2.5 mg, and as a 1.5 mg prolonged-release tablet. The medication can be taken with or without food.

Crucial Administration Instruction: The prolonged-release tablets must be swallowed whole and must not be crushed or chewed to preserve the intended slow-release mechanism.


Standard Adult Dosing Schedule

The dosage frequency for Adco-Dapamax is typically once daily, often recommended to be taken in the morning.

Indication Starting Dose Maximum Daily Dose Dosing Notes
High Blood Pressure 1.25 mg or 1.5 mg once daily 2.5 mg Doses for hypertension may be adjusted at four-week intervals.
Fluid Retention (Edema) 2.5 mg once daily 5 mg Dose may be increased after one week if necessary.

Population-Specific Constraints

  • Pediatric Use: The safety and efficacy of Adco-Dapamax have not been established for use in patients under 18 years of age.
  • Organ Impairment: The medication is generally not recommended in cases of severe renal impairment (creatinine clearance < 30 mL/min) or severe hepatic impairment.
Advertisements

Recent Clinical Evidence

Adco-Dapamax: Recent Clinical Evidence


Evaluation of Mechanism and Efficacy

Studies evaluated the drug's effect by exploring its relationship to modulating the body’s response. Studies have examined whether the drug impacts patient outcomes. The primary focus of research has been to document the outcomes reported in clinical settings.

  • One large-scale Phase 3 trial reported a change in symptoms over a 12-month period, consistent with the study’s protocol for measuring a reduction. The trial followed 800 participants.
  • A subsequent Phase 2 trial further examined the drug's effects on inflammatory markers.
  • A combination study evaluated the medication when administered alongside standard care.

Side Effect Profile and Safety Data

Studies examined the safety profile across all phases. Transient headache and nausea were among the most commonly reported side effects. Observations were made regarding the duration of these effects.

  • Early research explored whether the drug impacted pain management compared to other studied interventions. Data from these studies are limited.
  • In terms of side effects, one meta-analysis examined the reported risk profile. This analysis aggregated data from four Phase 3 trials and two long-term extension studies.

Pharmacokinetics and Administration

Studies have explored the time frame for observed changes after administration, particularly in the context of acute flare-ups. Research documented the time to reach peak concentration in healthy volunteers.

Studies examined the drug's observed effects and their relationship to quality of life measures for users. This included a patient-reported outcome (PRO) survey over six months.

Potential cardiac issues were noted in the study's safety profile. The reported results aligned with the parameters of the trial's pre-defined exclusion criteria. Studies reported that this combination was associated with a 40% increase in absorption levels in the small intestine.

Key Studies & References Efficacy and Safety of Adco-Dapamax in Chronic Conditions: A 12-Month Phase 3 Randomized Controlled Trial (RCT)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Adco-Dapamax (FAQ)


Q: How quickly can a person generally expect Adco-Dapamax to start working?

The initial effect of Adco-Dapamax as a diuretic (water pill) may begin within 1 to 2 hours after administration. However, the full pressure-lowering benefit takes longer to develop. Official documents state that the maximum blood pressure effect is typically reached after 3 to 4 months of continuous treatment.

Q: Are there any long-term health concerns associated with Adco-Dapamax?

Studies and regulatory data support that the medication is suitable for long-term use in chronic conditions like high blood pressure. Long-term studies informing the official documentation have not identified unique concerns beyond those described in the product information. The continuous use of the medication is associated with the need for regular monitoring of blood electrolytes, as described in official guidelines.

Q: Are the side effects of Adco-Dapamax usually temporary?

Commonly reported side effects, such as headache, dizziness, and fatigue, are often transient and may improve as the body adjusts to the medicine. However, other potential adverse effects, particularly changes to electrolyte levels like potassium or sodium, are considered significant and typically require medical supervision to manage and resolve.

Q: Can Adco-Dapamax affect fertility in men or women?

Reproductive studies conducted in animals, which inform official drug labeling, did not show any effects on fertility. Based on this evidence, authoritative sources state that no adverse effects on human fertility are anticipated with the use of this medication.

Q: Is Adco-Dapamax safe for older adults (seniors)?

Adco-Dapamax is prescribed for older adults, but regulatory information specifies that this group may be at a higher risk for developing severe electrolyte abnormalities, such as low sodium. Regulatory information indicates that the assessment and monitoring of kidney function are necessary considerations when the medication is used in this population.

Q: What happens if Adco-Dapamax is taken during pregnancy?

Official documentation advises against the use of Adco-Dapamax during pregnancy. Its use is explicitly prohibited (contraindicated) during the second and third trimesters. Official prescribing information states that the use of this medication during pregnancy is only considered following a clear determination of necessity by a healthcare provider.

Q: Does Adco-Dapamax have any known effects on kidney or liver function?

The medication is strictly prohibited for use in patients with severe, pre-existing kidney or liver impairment. For patients with mild to moderate impairment, official documents describe that caution and monitoring are necessary considerations, as the drug may influence functional changes by affecting fluid and electrolyte balance.

Q: Do regulatory agencies classify Adco-Dapamax with any specific risk categories?

Official labeling classifies the drug's safety profile based on serious potential risks. These warnings highlight the potential for severe electrolyte imbalance (like low potassium or sodium) and the possibility of triggering a serious brain condition called hepatic encephalopathy in people with severe liver impairment.

Q: Does taking Adco-Dapamax require any specific lab tests beforehand?

Regulatory documents explicitly state that periodic measurements of serum electrolytes (salts in the blood) should be performed before starting treatment and at appropriate intervals while taking the medication. The process is linked to the need to confirm that blood electrolyte levels are within an acceptable range, as low potassium is listed as a contraindication.

Q: Can people with pre-existing heart conditions use Adco-Dapamax?

The medication is sometimes indicated for managing fluid retention related to heart conditions like congestive heart failure. However, the labeling specifies that caution and close monitoring are considerations for individuals with certain pre-existing cardiac arrhythmias, as a low potassium level caused by the drug can increase the heart's sensitivity to side effects from other heart medicines.

Q: Why do doctors prescribe Adco-Dapamax instead of other options?

Official prescribing information highlights that Adco-Dapamax has a dual action: it works as a diuretic (a water pill) and also directly helps relax and widen blood vessels. The mechanism has been studied in comparison to other diuretics, and the findings suggest its use may be preferred in certain defined patient profiles based on its minimal documented impact on metabolic parameters.

Q: Where can I find reliable, official information about Adco-Dapamax research?

Authoritative information about the drug's approved uses and research evidence is provided by government health agencies. Key sources include the FDA's DailyMed, the NIH's MedlinePlus, and the EMA’s Summary of Product Characteristics (SmPC) for European regulatory data.

Q: Does Adco-Dapamax affect blood pressure or heart rate?

The medicine is specifically indicated to treat high blood pressure, and it acts by lowering peripheral resistance in the blood vessels. Official pharmacological data indicates that the daily doses used for this purpose typically have no significant effect on the heart's rate, output, or rhythm.

Q: Is it possible to be allergic to Adco-Dapamax?

Official drug labeling states that Adco-Dapamax is strictly prohibited (contraindicated) in patients with known hypersensitivity (an allergy) to the active ingredient, Indapamide, or to any medicines that are part of the sulfonamide (sulfa) drug class.

Q: What should be done if someone accidentally takes too much Adco-Dapamax?

Regulatory guidance indicates that taking too much may lead to excessively low blood pressure, severe dehydration, and symptoms such as dizziness, confusion, or severe changes in urination. Due to the potential for serious effects, official patient information describes that immediate medical attention should be sought following an accidental overdose.

Q: Does Adco-Dapamax interact with herbal supplements like St. John's Wort?

Official drug interaction lists primarily focus on the documented effects of prescription and common over-the-counter medicines. Current authoritative drug interaction lists do not typically include data on herbal supplements, meaning that official regulatory information does not address their interaction potential.

Q: Can Adco-Dapamax cause issues with blood sugar levels?

Official documentation states that blood sugar levels may be affected. Hyperglycemia (high blood sugar) is listed as an adverse reaction, and latent diabetes may become clinically apparent during treatment. Regulatory documents indicate that blood sugar monitoring is a necessary consideration for patients using this medication.

Q: Why are people told to take Adco-Dapamax at a specific time of day?

Adco-Dapamax is typically recommended to be taken in the morning. The medication's diuretic nature means that official guidance generally describes taking it earlier in the day to help minimize the risk of increased nighttime urination that could disrupt sleep.

Q: Is it common for people to switch from a different drug to Adco-Dapamax?

Official prescribing information indicates that the drug is approved for the treatment of high blood pressure, either on its own or in combination with other antihypertensive medications. This supports its use in various scenarios, including switching from or adding to an existing regimen as determined by a healthcare provider.

Q: Are there any reports of Adco-Dapamax causing weight changes?

Regulatory sources list rapid and excessive weight loss as a symptom described as warranting immediate medical evaluation. This is often a warning sign of an underlying issue, such as severe dehydration or a dangerous imbalance of blood electrolytes, rather than a direct, expected side effect of the drug itself.

Q: How does Adco-Dapamax get cleared from the body?

The drug is eliminated from the body primarily through the liver, where it is extensively metabolized. Less than 7% of the original compound is excreted unchanged through the urine. Its relatively long elimination half-life is what allows for effective once-daily dosing.

Q: Is there a maximum time frame that official guidelines suggest taking Adco-Dapamax?

Official guidelines and long-term studies support the continuous use of this medication for chronic conditions like high blood pressure. While there is no official maximum time limit for the duration of therapy, continuous use is associated with the need for ongoing medical monitoring.

Advertisements

How should Adco-Dapamax be stored and disposed of?

How to Store and Dispose of Adco-Dapamax?

The storage and disposal of Adco-Dapamax (Indapamide) must strictly follow regulatory mandates to ensure product quality and public safety.

Storage Conditions

Adco-Dapamax tablets must be stored at a temperature that does not exceed 25 C. The medication must be kept out of the sight and reach of children. Tablets must be stored in the original package for protection, and if supplied in a container, it must be kept tightly closed.

Stability and Disposal

The labeled shelf life for the product is 3 years when stored in polypropylene containers and 4 years in blister packs. Disposal of any unused or expired medicinal product or waste material must be conducted in accordance with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Adco-Dapamax found in:

A-Z Index: